Trial site
Altnagelvin Area Hospital
- 12running trials
- 7closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Idiopathic pulmonary fibrosis6 trials
- Chronic kidney disease5 trials
- Coronary artery disease4 trials
- Obesity3 trials
- Type 2 diabetes3 trials
- Gastric and oesophageal cancer2 trials
- Lung cancer2 trials
- Peripheral artery disease2 trials
- Stroke2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Endometrial cancer1 trial
- and 7 more
- Phase
- Phase 310 trials
- Phase 26 trials
- Phase 2/31 trial
- Status
- Active, not recruiting6 trials
- Completed6 trials
- Recruiting5 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Boehringer Ingelheim4 trials
- Daiichi Sankyo3 trials
- CSL Behring2 trials
- Eli Lilly and Company2 trials
- Fondazione Ricerca e Innovazione Cardiovascolare ETS1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Active, not recruiting
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
Active, not recruiting
Active, not recruiting
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer2 recruiting
- Lung cancer2 recruiting
- Type 2 diabetes2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Chronic kidney disease1 recruiting
- Coronary artery disease1 recruiting
- Endometrial cancer1 recruiting
- Head and neck cancer1 recruiting
- Melanoma1 recruiting
- Obesity1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Peripheral artery disease1 recruiting
- Prostate cancer1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
Completed
Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Completed
Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke
Site data: ClinicalTrials.govUpdated 18 Nov 2026